Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1992 | 1 |
2011 | 1 |
2013 | 1 |
2020 | 1 |
2021 | 1 |
2024 | 0 |
PubMed for id: 1665858
4 results
Results by year
Filters applied: . Clear all
Page 1
Activation of Receptor Tyrosine Kinases Mediates Acquired Resistance to MEK Inhibition in Malignant Peripheral Nerve Sheath Tumors.
Cancer Res. 2021 Feb 1;81(3):747-762. doi: 10.1158/0008-5472.CAN-20-1992. Epub 2020 Nov 17.
Cancer Res. 2021.
PMID: 33203698
Free PMC article.
Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.
Peacock JD, Cherba D, Kampfschulte K, Smith MK, Monks NR, Webb CP, Steensma M.
Peacock JD, et al.
J Transl Med. 2013 Sep 17;11:213. doi: 10.1186/1479-5876-11-213.
J Transl Med. 2013.
PMID: 24040940
Free PMC article.
Item in Clipboard
Phenotypic reversion of invasive neurofibromin-deficient schwannoma by FTS: Ras inhibition reduces BMP4/Erk/Smad signaling.
Barkan B, Kloog Y, Ehrlich M.
Barkan B, et al.
Mol Cancer Ther. 2011 Aug;10(8):1317-26. doi: 10.1158/1535-7163.MCT-10-1087. Epub 2011 Jun 1.
Mol Cancer Ther. 2011.
PMID: 21632464
Item in Clipboard
Expanded spectrum of viral therapy in the treatment of nervous system tumors.
Markert JM, Coen DM, Malick A, Mineta T, Martuza RL.
Markert JM, et al.
J Neurosurg. 1992 Oct;77(4):590-4. doi: 10.3171/jns.1992.77.4.0590.
J Neurosurg. 1992.
PMID: 1326612
Item in Clipboard
Cite
Cite